Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

VKTXVKTX
Showing 8 of 23 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in VIKING THERAPEUTICS INC

Bank of New York Mellon Corp holds 407,840 shares of VKTX (VIKING THERAPEUTICS INC), worth $15.9M as of 2026-Q2. The position was decreased (-10.2% shares). VKTX represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$15.9M

Current Shares

407,840

Total Value Change

-$10.8M

Total Shares Change

-13,724

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
407,840
-10.2%
$15.9M0.0%$39.01
0
2026-Q1
Decreased
454,063
-4.3%
$14.8M0.0%$31.93
0
2025-Q4
Decreased
474,621
-5.0%
$16.7M0.0%$35.32
0
2025-Q3
Increased
499,786
+12.9%
$13.1M0.0%$25.81
32
2025-Q2
Decreased
442,675
-14.6%
$11.7M0.0%$26.52
0
2025-Q1
Increased
518,298
+11.9%
$12.5M0.0%$25.65
31
2024-Q4
Increased
462,964
+9.8%
$18.6M0.0%$39.77
31
2024-Q3
Increased
421,564
+3.5%
$26.7M0.0%$61.63
30

Other major holders of VKTX: BlackRock Finance, Inc., FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used